RU2003117557A - METHOD FOR PREVENTING COMPLICATIONS OF HERPES-VIRAL INFECTION IN CORNERAL DAMAGES - Google Patents

METHOD FOR PREVENTING COMPLICATIONS OF HERPES-VIRAL INFECTION IN CORNERAL DAMAGES

Info

Publication number
RU2003117557A
RU2003117557A RU2003117557/14A RU2003117557A RU2003117557A RU 2003117557 A RU2003117557 A RU 2003117557A RU 2003117557/14 A RU2003117557/14 A RU 2003117557/14A RU 2003117557 A RU2003117557 A RU 2003117557A RU 2003117557 A RU2003117557 A RU 2003117557A
Authority
RU
Russia
Prior art keywords
herpes
corneral
damages
viral infection
preventing complications
Prior art date
Application number
RU2003117557/14A
Other languages
Russian (ru)
Other versions
RU2230566C1 (en
Inventor
Ирина Александровна Захарова
Владимир Юрьевич Махмутов
Дмитрий Олегович Найдюк
Original Assignee
Ирина Александровна Захарова
Владимир Юрьевич Махмутов
Дмитрий Олегович Найдюк
Filing date
Publication date
Application filed by Ирина Александровна Захарова, Владимир Юрьевич Махмутов, Дмитрий Олегович Найдюк filed Critical Ирина Александровна Захарова
Priority to RU2003117557/14A priority Critical patent/RU2230566C1/en
Priority claimed from RU2003117557/14A external-priority patent/RU2230566C1/en
Application granted granted Critical
Publication of RU2230566C1 publication Critical patent/RU2230566C1/en
Publication of RU2003117557A publication Critical patent/RU2003117557A/en

Links

Claims (1)

Способ профилактики осложнений герпес - вирусной инфекции при повреждениях роговицы, включающий в себя медикаментозное лечение, отличающийся тем, что дополнительно назначается а - интерферон в виде присыпок, в дозе 1000 ME на поврежденный участок роговицы в течение первых трех дней 2 раза в день, а в следующие три дня 1 раз в день.A method for the prevention of complications of herpes virus infection in corneal injuries, which includes medication, characterized in that it is additionally prescribed a - interferon in the form of powders, at a dose of 1000 ME per damaged area of the cornea during the first three days 2 times a day, and the next three days 1 time per day.
RU2003117557/14A 2003-06-11 2003-06-11 Method for prophylaxis of complication in herpes viral infection in cornea damage RU2230566C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003117557/14A RU2230566C1 (en) 2003-06-11 2003-06-11 Method for prophylaxis of complication in herpes viral infection in cornea damage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003117557/14A RU2230566C1 (en) 2003-06-11 2003-06-11 Method for prophylaxis of complication in herpes viral infection in cornea damage

Publications (2)

Publication Number Publication Date
RU2230566C1 RU2230566C1 (en) 2004-06-20
RU2003117557A true RU2003117557A (en) 2004-12-27

Family

ID=32847050

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003117557/14A RU2230566C1 (en) 2003-06-11 2003-06-11 Method for prophylaxis of complication in herpes viral infection in cornea damage

Country Status (1)

Country Link
RU (1) RU2230566C1 (en)

Similar Documents

Publication Publication Date Title
EP1669364A3 (en) Methods and compositions for treating hepatitis C virus
IL171991A0 (en) Use of an interferon polypeptide in the preparation of a pharmaceutical composition for treating virus infection and a method of treating a virus-infected non human subject
TR200402565T4 (en) Use of ß-L-2'-deoxy-nucleosides in the treatment of hepatitis delta virus infection
IL143512A (en) Azabicycloalkanes, pharmaceutical compositions comprising same and use thereof for the manufacture of medicaments for the prevention or treatment of infection by immunodeficiency virus
WO2007038507A3 (en) Modified 4'-nucleosides as antiviral agents
IL215891A (en) Hepatitis c virus serine protease inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment of hepatitis c virus infections
WO2003051306A3 (en) N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
WO2004002999A8 (en) Modified 2' and 3' -nucleoside produgs for treating flaviridae infections
AP2006003542A0 (en) Administration of TLR7 ligands and prodrugs for treatment of infection by hepatitis C virus.
WO2005055955A3 (en) DOSING METHODS FOR ß-D-2’,3’-DIDEOXY-2’,3’-DIDEHYDRO-5-FLUOROCYTIDINE ANTIVIRAL THERAPY
WO2003053360A3 (en) Treatment of ebv and khsv infection and associated abnormal cellular proliferation
PL1680112T3 (en) N-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin or a pharmaceutically salt thereof for use in the treatment of insulin resistance
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
WO2000041463A3 (en) Combination of hepatitis b vaccine with antiviral agents
ZA991029B (en) Composition and methods for treatment of hiv infections.
RU2003117557A (en) METHOD FOR PREVENTING COMPLICATIONS OF HERPES-VIRAL INFECTION IN CORNERAL DAMAGES
WO2004030631A3 (en) Anti-cancer and anti-infectious disease compositions and methods for using same
WO2006094640A3 (en) Roflumilast and integrin inhibitor combination and method of treatment
WO2005032453A3 (en) Antiviral agents for the treatment, control and prevention of infections by coronaviruses
WO2001010454A3 (en) Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection
DE69925312D1 (en) BUPROPION FOR THE TREATMENT OF VIRAL DISEASES
WO2004013298A3 (en) 2',3'-dideoxynucleoside analogues for the treatment or prevention of flavivitridae infections
DK0458587T3 (en) Treatment of ocular hypertension with a synergistic combination for ophthalmic use
WO2001066100A3 (en) Pharmaceutical composition
WO2005060978A3 (en) Polymetaphosphate based formulations for therapy of microcrystalline arthropathies